ConductScience.org, home

Paper32229068

The quest for improving the management of breast cancer by functional imaging: The discovery and development of 16α-[18F]fluoroestradiol (FES), a PET radiotracer for the estrogen receptor, a historical review.

Katzenellenbogen JA. Nucl Med Biol, 2021. Cited by 54 papers, by iCite.

Cite this record

ConductScience Library. The quest for improving the management of breast cancer by functional imaging: The discovery and development of 16α-[18F]fluoroestradiol (FES), a PET radiotracer for the estrogen receptor, a historical review. Papers, record 32229068. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32229068

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The quest for improving the management of breast cancer by functional imaging: The discovery and development of 16α-[18F]fluoroestradiol (FES), a PET radiotracer for the estrogen receptor, a historical review.
PubMed
Journal
Nucl Med Biol
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Review
PubMed
Citations, by iCite
54
iCite
Relative citation ratio, by iCite
3.33
iCite
Revised in PubMed
2026-10-01
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Katzenellenbogen JAJohn A

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
EstradiolMajor topic
Positron-Emission TomographyMajor topic
Receptors, EstrogenMajor topic
Animals
Female
Humans
History, 20th Century
History, 21st Century
Radioactive Tracers

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 CA025836NCI NIH HHSUnited StatesR01CA025836PubMed and NIHNIH RePORTER
R37 CA025836NCI NIH HHSUnited StatesR01CA025836PubMed and NIHNIH RePORTER
R37CA025836NIHNIH RePORTER

Download CSV of grants

References144

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17830275Fluorine-18-labeled progestin 16 alpha, 17 alpha-dioxolanes: development of high-affinity ligands for the progesterone receptor with high in vivo target site selectivity.J Med Chem1995https://conductscience.org/library/papers/7830275PubMed
212884843SNM highlights as history: 1983.J Nucl Med2003https://conductscience.org/library/papers/12884843PubMed
325476421Rapid synthesis of [18F]fluoroestradiol: remarkable advantage of microwaving over conventional heating.J Labelled Comp Radiopharm2014https://conductscience.org/library/papers/25476421PubMed
410334533Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer.J Clin Oncol1999https://conductscience.org/library/papers/10334533PubMed
511882788Theory and practice of imaging saturable binding sites.Invest Radiol2002https://conductscience.org/library/papers/11882788PubMed
625520392Longitudinal noninvasive imaging of progesterone receptor as a predictive biomarker of tumor responsiveness to estrogen deprivation therapy.Clin Cancer Res2015https://conductscience.org/library/papers/25520392PubMed
7164893Iodohexestrols. II. Characterization of the binding and estrogenic activity of iodinated hexestrol derivatives, in vitro and in vivo.Biochemistry1975https://conductscience.org/library/papers/164893PubMed
831732674Recent Advances in Imaging Steroid Hormone Receptors in Breast Cancer.J Nucl Med2020https://conductscience.org/library/papers/31732674PubMed
98003436Synthesis of (17 alpha,20E/Z)iodovinyl testosterone and 19-nortestosterone derivatives as potential radioligands for androgen and progesterone receptors.J Steroid Biochem Mol Biol1994https://conductscience.org/library/papers/8003436PubMed
106292423
Nonsteroidal estrogens: synthesis and estrogen receptor binding affinity of derivatives of (3R*,4S*)-3,4-bis(4-hydroxyphenyl)hexane (hexestrol) and (2R*,3S*)-2,3-bis(4-hydroxyphenyl)pentane (norhexestrol) functionalized on the side chain.
J Med Chem1982https://conductscience.org/library/papers/6292423PubMed
118401374
Titration of the in vivo uptake of 16 alpha-[18F]fluoroestradiol by target tissues in the rat: competition by tamoxifen, and implications for quantitating estrogen receptors in vivo and the use of animal models in receptor-binding radiopharmaceutical development.
Nucl Med Biol1993https://conductscience.org/library/papers/8401374PubMed
127562040Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays.J Nucl Med1995https://conductscience.org/library/papers/7562040PubMed
13835556716 beta-[18F]fluoromoxestrol: a potent, metabolically stable positron emission tomography imaging agent for estrogen receptor positive human breast tumors.Life Sci1993https://conductscience.org/library/papers/8355567PubMed
1416459252Molecular targets.Nucl Med Biol2006https://conductscience.org/library/papers/16459252PubMed
151125197Iodohexestrols. I. Synthesis and photoreactivity of iodinated hexestrol derivatives.Biochemistry1975https://conductscience.org/library/papers/1125197PubMed
1610481160The Molecular Pharmacology of SERMs.Trends Endocrinol Metab1999https://conductscience.org/library/papers/10481160PubMed
1721982568Factors influencing the uptake of 18F-fluoroestradiol in patients with estrogen receptor positive breast cancer.Nucl Med Biol2011https://conductscience.org/library/papers/21982568PubMed
189794874Ovarian ablation in breast cancer, 1896 to 1998: milestones along hierarchy of evidence from case report to Cochrane review.BMJ1998https://conductscience.org/library/papers/9794874PubMed
1927491481
Phase II trial of neoadjuvant letrozole and lapatinib in Asian postmenopausal women with estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2)-positive breast cancer [Neo-ALL-IN]: Highlighting the TILs, ER expressional change after neoadjuvant treatment, and FES-PET as potential significant biomarkers.
Cancer Chemother Pharmacol2016https://conductscience.org/library/papers/27491481PubMed
20170183311 beta-methoxy-, 11 beta-ethyl- and 17 alpha-ethynyl-substituted 16 alpha-fluoroestradiols: receptor-based imaging agents with enhanced uptake efficiency and selectivity.J Med Chem1990https://conductscience.org/library/papers/1701833PubMed

See all 144 referencesDownload CSV of references

Cited by32

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.

PMIDTitleJournalYearIn PapersSource
42776062The Next Frontier in Quantitative Co-Clinical Imaging to Advance Functional Precision Oncology.Clin Cancer Res2026https://conductscience.org/library/papers/42776062PubMed
42722783Macrocycle Chelator Conjugation on the C3 Hydroxyl Group of 17β-Estradiol reduces Estrogen Receptor Binding.Mol Imaging Biol2026https://conductscience.org/library/papers/42722783PubMed
42492092[18F]FDG PET/MRI for axillary staging in node positive breast cancer patients receiving primary systemic therapy. A prospective single arm trial.Breast2026https://conductscience.org/library/papers/42492092PubMed
42078117
Rationale and Trial Design of DAWNA-FES Trial: Single-Arm Phase II Study of Endocrine Therapy With Dalpiciclib After Progression on CDK4/6 Inhibition Based on [18F]FES PET/CT in Patients With HR+/HER2- Advanced Breast Cancer.
Cancer Innov2026https://conductscience.org/library/papers/42078117PubMed
41940065A comprehensive review of de novo oligometastatic breast cancer: Current treatment options, surgical outcomes, and systemic therapy.North Clin Istanb2026https://conductscience.org/library/papers/41940065PubMed
40968016Hybrid [18F] Fluoroestradiol Brain PET/CT/MRI for Detection of Estrogen Receptor-Positive Intracranial Metastases Compared with MRI and Vertex-to-Below the Knees PET Imaging.AJNR Am J Neuroradiol2025https://conductscience.org/library/papers/40968016PubMed
40820148A novel solid phase synthesis of an estradiol derivative and preclinical evaluation for targeting estrogen-receptor positive breast cancer.Sci Rep2025https://conductscience.org/library/papers/40820148PubMed
40773017Quantitative and simplified [18F] fluoroestradiol positron emission tomography (PET) measures of brain estrogen receptor expression.Eur J Nucl Med Mol Imaging2026https://conductscience.org/library/papers/40773017PubMed
40427142The Role of [18F]FES PET/CT in Breast Cancer Management: An Umbrella Review.Cancers (Basel)2025https://conductscience.org/library/papers/40427142PubMed
39333775EDB-FN-targeted probes for near infrared fluorescent imaging and positron emission tomography imaging of breast cancer in mice.Sci Rep2024https://conductscience.org/library/papers/39333775PubMed
39272726Radiotracer Innovations in Breast Cancer Imaging: A Review of Recent Progress.Diagnostics (Basel)2024https://conductscience.org/library/papers/39272726PubMed
39170834Characterization of an Estrogen Receptor α-Selective 18 F-Estradiol PET Tracer.World J Nucl Med2024https://conductscience.org/library/papers/39170834PubMed
39136565Estrogen Receptor-targeted PET Imaging for Breast Cancer.Radiology2024https://conductscience.org/library/papers/39136565PubMed
39123367Radiosynthesis and Preclinical Evaluation of 18F-Labeled Estradiol Derivatives with Different Lipophilicity for PET Imaging of Breast Cancer.Cancers (Basel)2024https://conductscience.org/library/papers/39123367PubMed
39058489ER-Targeted PET for Initial Staging and Suspected Recurrence in ER-Positive Breast Cancer.JAMA Netw Open2024https://conductscience.org/library/papers/39058489PubMed
38993095
A Single-Arm Phase II Clinical Trial of Fulvestrant Combined with Neoadjuvant Chemotherapy of ER+/HER2- Locally Advanced Breast Cancer: Integrated Analysis of 18F-FES PET-CT and Metabolites with Treatment Response.
Cancer Res Treat2025https://conductscience.org/library/papers/38993095PubMed
38902275In vivo brain estrogen receptor density by neuroendocrine aging and relationships with cognition and symptomatology.Sci Rep2024https://conductscience.org/library/papers/38902275PubMed
38753748Molecular Imaging of Steroid Receptors in Breast Cancer.Cancer J2024https://conductscience.org/library/papers/38753748PubMed
38338854Imaging Molecular Targets and Metabolic Pathways in Breast Cancer for Improved Clinical Management: Current Practice and Future Perspectives.Int J Mol Sci2024https://conductscience.org/library/papers/38338854PubMed
37494470Expression of the excitatory opsin ChRERα can be traced longitudinally in rat and nonhuman primate brains with PET imaging.Sci Transl Med2023https://conductscience.org/library/papers/37494470PubMed

See all 32 cited byDownload CSV of cited by

Genes10

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32229068

GET https://conductscience.org/api/papers/v1/32229068/references?page=2